Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease

Published:2022-07-01 Issue:8 Volume:54 Page:1133-1139
ISSN:1672-9145
Container-title:Acta Biochimica et Biophysica Sinica
language:en
Short-container-title:ABBS

Author:

Zou Zhihui,Shan Huizhuang,Sun Demeng,Xia Li,Shi Yulong,Wan Jiahui,Zhou Aiwu,Wu Yunzhao,Xu Hanzhang,Lei Hu,Xu Zhijian,Wu Yingli

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine,Biochemistry,Biophysics

Link

https://engine.scichina.com/doi/pdf/4EBA2AD2BCE8455F9BF5884E9AF4D3BD

Reference31 articles.

1. Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol, 2020, 20: 269-270.

2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet, 2020, 395: 470-473.

3. Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020, 5: 536-544.

4. Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM. Repurposed antiviral drugs for Covid-19 — interim WHO solidarity trial results. N Engl J Med, 2021, 384: 497-511.

5. Wang L, Hu W, Fan C. Structural and biochemical characterization of SADS‐CoV papain‐like protease 2. Protein Sci, 2020, 29: 1228-1241.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease;Future Pharmacology;2024-08-17

2. The sesquiterpenes with the COVID-19 M^pro inhibitory activity from the Carpesium abrotanoides L.;Natural Product Research;2023-07-05

3. The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm;Frontiers in Pharmacology;2023-03-09

4. Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 Applications;2023-02-22

5. Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2;Virus Research;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3